Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?When will tenofovir alafenide come off patent in canada?Is januvia still on the market?How does insurance coverage impact nivolumab's duration?Pramlintide acetate price?
The provided information doesn’t include any incidence rates for muscle aches/myalgias in pediatric patients taking Lipitor (atorvastatin). Without that data, it isn’t possible to state how frequently muscle aches occur in children on this medication.
In statin studies and safety monitoring, “muscle aches” typically corresponds to patient-reported myalgia (pain, soreness, or aches without necessarily confirmed muscle injury) and may also be tracked alongside lab or clinical markers such as elevated creatine kinase (CK). Incidence figures depend on the exact definition used in the study or label (myalgia alone vs. myopathy vs. rhabdomyolysis).
For incidence in children, the rates would usually come from: - Pediatric clinical trials of atorvastatin (including any adverse event tables for myalgia/muscle pain) - The drug’s prescribing information (pediatric section, adverse reactions) - Published safety summaries tied to those trials
If you paste the relevant excerpt from the Lipitor prescribing information or the specific pediatric trial/report you’re looking at, I can pull out the exact incidence of muscle aches/myalgia for that source.
Other Questions About Aches :